Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent Biosciences, Inc.

7.01
-0.4000-5.40%
Post-market: 6.84-0.1700-2.43%19:58 EST
Volume:972.04K
Turnover:6.91M
Market Cap:798.09M
PE:-3.61
High:7.48
Open:7.45
Low:6.90
Close:7.41
Loading ...
Mar 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 03, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Major Issues Report

8-K - Current report
Nov 30, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 19, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals